Jpmorgan Chase & CO Cryo Cell International Inc Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CCEL
# of Institutions
16Shares Held
920KCall Options Held
0Put Options Held
0-
Hamilton Lane Advisors LLC410KShares$3.59 Million2.79% of portfolio
-
Sfi Advisors, LLC Montclair, NJ165KShares$1.45 Million0.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA117KShares$1.02 Million0.0% of portfolio
-
Massmutual Trust CO Fsb111KShares$971,5560.02% of portfolio
-
Geode Capital Management, LLC Boston, MA39.9KShares$348,7750.0% of portfolio
About CRYO CELL INTERNATIONAL INC
- Ticker CCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 8,519,250
- Market Cap $74.5M
- Description
- Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...